Protalix BioTherapeutics (PLX) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.03% |
| Dec 31, 2025 | -273.90% |
| Sep 30, 2025 | 60.65% |
| Jun 30, 2025 | -27.40% |
| Mar 31, 2025 | 170.81% |
| Dec 31, 2024 | -181.93% |
| Sep 30, 2024 | 254.30% |
| Jun 30, 2024 | -179.77% |
| Mar 31, 2024 | 65.65% |
| Dec 31, 2023 | 281.41% |
| Sep 30, 2023 | -197.55% |
| Jun 30, 2023 | -17.74% |
| Mar 31, 2023 | 500.00% |
| Dec 31, 2022 | -150.00% |
| Sep 30, 2022 | 183.78% |
| Jun 30, 2022 | -164.63% |
| Mar 31, 2022 | -48.88% |
| Dec 31, 2021 | 30.23% |
| Sep 30, 2021 | 22.42% |
| Jun 30, 2021 | -27.20% |
| Mar 31, 2021 | 712.70% |
| Dec 31, 2020 | -161.76% |
| Sep 30, 2020 | -51.89% |
| Jun 30, 2020 | 221.21% |
| Mar 31, 2020 | 113.17% |
| Dec 31, 2019 | -227.81% |
| Sep 30, 2019 | 959.46% |
| Jun 30, 2019 | -78.24% |
| Mar 31, 2019 | 162.27% |
| Dec 31, 2018 | -362.50% |
| Sep 30, 2018 | -28.28% |
| Jun 30, 2018 | -41.77% |
| Mar 31, 2018 | -14.14% |
| Dec 31, 2017 | 110.14% |
| Sep 30, 2017 | -57.28% |
| Jun 30, 2017 | 46.82% |
| Mar 31, 2017 | 88.03% |
| Dec 31, 2016 | -25.48% |
| Sep 30, 2016 | -51.54% |
| Jun 30, 2016 | 29.08% |
| Mar 31, 2016 | 6,175.00% |
| Dec 31, 2015 | -96.88% |
| Sep 30, 2015 | -45.06% |
| Jun 30, 2015 | 135.35% |
| Mar 31, 2014 | 18.47% |
| Dec 31, 2013 | -32.11% |
| Sep 30, 2013 | -53.22% |
| Jun 30, 2013 | 8.88% |
| Mar 31, 2013 | 155.78% |
| Dec 31, 2012 | -67.40% |
| Sep 30, 2012 | 224.89% |
| Jun 30, 2012 | -70.74% |
| Mar 31, 2012 | 15.06% |
| Dec 31, 2011 | -28.53% |
| Sep 30, 2011 | -30.24% |
| Jun 30, 2011 | -45.78% |
| Mar 31, 2011 | 150.63% |
| Dec 31, 2010 | -22.64% |